Modafinil's Effects on Cognition in Remitted MDD
Conditions: Major Depressive Disorder; Cognitive Impairment Interventions: Drug: Modafinil; Drug: Placebo Sponsors: St. Michael's Hospital, Toronto; Ontario Ministry of Health and Long Term Care; The Canadian Biomarker Integration Network in Depression Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Condition: Multiple Sclerosis Interventions: Behavioral: Telephone-based Cognitive Behavioral Therapy; Drug: Modafinil Sponsors: University of Michigan; University of Washington; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Modafinil's Effects on Cognition in Remitted MDD
Conditions: Major Depressive Disorder; Cognitive Impairment Interventions: Drug: Modafinil; Drug: Placebo Sponsors: St. Michael's Hospital, Toronto; Ontario Ministry of Health and Long Term Care; The Canadian Biomarker Integration Network in Depression Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Condition: Multiple Sclerosis Interventions: Behavioral: Telephone-based Cognitive Behavioral Therapy; Drug: Modafinil Sponsors: University of Michigan; University of Washington; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Modafinil's Effects on Cognition in Remitted MDD
Conditions: Major Depressive Disorder; Cognitive Impairment Interventions: Drug: Modafinil; Drug: Placebo Sponsors: St. Michael's Hospital, Toronto; Ontario Ministry of Health and Long Term Care; The Canadian Biomarker Integration Network in Depression Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Condition: Multiple Sclerosis Interventions: Behavioral: Telephone-based Cognitive Behavioral Therapy; Drug: Modafinil Sponsors: University of Michigan; University of Washington; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Modafinil's Effects on Cognition in Remitted MDD
Conditions: Major Depressive Disorder; Cognitive Impairment Interventions: Drug: Modafinil; Drug: Placebo Sponsors: St. Michael's Hospital, Toronto; Ontario Ministry of Health and Long Term Care; The Canadian Biomarker Integration Network in Depression Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Condition: Multiple Sclerosis Interventions: Behavioral: Telephone-based Cognitive Behavioral Therapy; Drug: Modafinil Sponsors: University of Michigan; University of Washington; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
Modafinil's Effects on Cognition in Remitted MDD
Conditions: Major Depressive Disorder; Cognitive Impairment Interventions: Drug: Modafinil; Drug: Placebo Sponsors: St. Michael's Hospital, Toronto; Ontario Ministry of Health and Long Term Care; The Canadian Biomarker Integration Network in Depression Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2018 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
Condition: Healthy Volunteers Interventions: Drug: TAK-925; Drug: TAK-925 Placebo; Drug: Modafinil; Drug: Modafinil Placebo Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2018 Category: Research Source Type: clinical trials
